Author

Leslie Anchling

SERUM LEVELS OF INFLIXIMAB AND ADALIMUMAB BIOSIMILARS CAN BE MEASURED EQUIVALENTLY TO ORIGINATOR DRUGS BY QUANTUM BLUE RAPID TESTING AS TOOL FOR THERAPEUTIC DRUG MONITORING
SERUM LEVELS OF INFLIXIMAB AND ADALIMUMAB BIOSIMILARS CAN BE MEASURED EQUIVALENTLY TO ORIGINATOR DRUGS BY QUANTUM BLUE RAPID TESTING AS TOOL FOR THERAPEUTIC DRUG MONITORING

SERUM LEVELS OF INFLIXIMAB AND ADALIMUMAB BIOSIMILARS CAN BE MEASURED EQUIVALENTLY TO ORIGINATOR DRUGS BY QUANTUM BLUE RAPID TESTING AS TOOL FOR THERAPEUTIC DRUG MONITORING
SERUM LEVELS OF INFLIXIMAB AND ADALIMUMAB BIOSIMILARS CAN BE MEASURED EQUIVALENTLY TO ORIGINATOR DRUGS BY QUANTUM BLUE RAPID TESTING AS TOOL FOR THERAPEUTIC DRUG MONITORING

Leslie Anchling  et al.

Item 1 - 2 / 2
1